Global Council

Dr. Bavaguthu Raghuram Shetty, popularly known as Raghu Bhai and BR, is a leading international business leader, entrepreneur, and philanthropist. He established the NMC Hospital in Abu Dhabi in 1975, the first of its kind in the country, with branches in Dubai and Sharjah following suit. These hospitals along with National Hospital, New National Medical Centre, Abu Dhabi, the state of the art NMC Specialty Hospitals in Abu Dhabi, Dubai, Al Ain and NMC Family Clinic, Dubai treat over one million patients a year.

The success story signaled the spawn of new enterprises, as Dr. Shetty set about his plans for diversification that led to major forays into a bewildering range of businesses spread over distribution in pharmaceuticals, FMCG brands, scientific/medical equipment, foodstuff, financial services, pharmaceutical manufacturing, hospitality, advertising and public relations, gold and diamond jewellery, real estate, information technology, engineering projects and services. Dr. Shetty has now embarked on the path of innovation in Technology in the fields of Nanotechnology, Bio-Technology, Cell Therapy and Tissue Culture.

Dr. Shetty's abiding interest in education has put him at the forefront of the largest community school in the region as its Chairman. Dr. Shetty has also invested in a medical institution in the north Indian state of Uttaranchal and has been appointed to the board of directors of the Haldawni Medical College. Besides heading numerous international groups, he is the Founder and Patron of the Indian Pharmaceutical Association in the Emirates and was President of the Abu Dhabi Cricket Council. Dr. Shetty also holds the post of Member of the Advisory Board (Financial Sector), Economic Department, Government of Dubai, UAE and the Pharmaceutical Committee, Dubai.

Awards and accolades have been heaped upon Dr. Shetty in recognition of services and contributions that have benefited organizations, individuals and institutions. These include the Karnataka Rajyothsava Award, the Rainbow Laurel Award instituted by the former Maharaja of Travancore, the Arch of India Gold Award of the NRI Institute in London, the epithet Dharmadarshi from Sri Krishna Mutt, Udupi. He is also the recipient of the 'Lifetime Achievement Award' that was conferred upon him on the occasion of the historic IPCA-FAPA joint Congress held in Mumbai. He was recently awarded the Pravasi Karma Ratna Award, the third Indian to be so honored.

Georgia State University of Atlanta, Georgia, USA has conferred the highest academic degree, the honorary degree of Doctor of Letters (D. Litt.); ‘in recognition of his noble service to humanity.’ Dr. B. R. Shetty was also conferred the 'Lifetime Achievement Award’ by the International Medical Integration Council and The Optimal Healthcare Group (India) for his outstanding contribution to the Healthcare Sector.

Further, in recognition of his accomplishments and exemplary acts of devotion, compassion and generosity towards the community and ultimately the development of the emirate of Abu Dhabi, Dr. B. R. Shetty was recently honored with the Order of Abu Dhabi. This award has been given in the memory of late Shaikh Zayed under the guidance and auspices of H. H. Sheikh Mohammed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi. Dr. B.R. Shetty was also conferred Pravasi Bharatiya Samman Award by President of India Dr. APJ Abdul Kalam on the concluding day of the Pravasi Bharatiya Divas for 2007 in New Delhi. This award was bestowed in recognition of Dr. Shetty’s outstanding contribution towards the betterment of the large NRI community.

Dr. Bandi Parthasaradhi Reddy, Chairman & Managing Director of Hetero group is academically endowed with a Post Graduate and Doctoral degrees with distinction in the field of synthetic chemistry. Prior to founding of Hetero Drugs Limited, Dr. B.P.S Reddy had a stint in a leading pharmaceutical company as the head of the Research & Development division. His sharp analysis and ability to synthesize various chemical compounds lead to the discovery of new processes, cost effective schemes for manufacturing of various pharmaceutical products. During the said period Dr. Reddy has the credit of introducing many new molecules for the first time in Indian pharmaceutical market.

A visionary the world knows as Dr. B.P.S. Reddy is the driving force behind this growing pharmaceutical phenomenon called “HETERO”. Dr. Reddy’s dream child, Hetero was born in the year 1993 as a small API unit. Today, 17 years later, the name is synonymous with leadership in pharmaceuticals with more than 18 manufacturing units and 8000 employees. An entity that is grown in stature by virtue of its combined strength in research, manufacturing and marketing.

Dr. Reddy steered Hetero towards the forefront of global pharmaceutical industry with his vision to be recognised as an aggressive company that combines its strength of R&D and manufacturing with definite advantages in terms of cost and chemistry with a strong emphasis on quality of the products. Dr. Reddy is now focusing on giving new dimensions to Hetero in terms of research and innovation programs in discovery research to take the company to greater heights.

Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization. Hetero is a leading international supplier with a rich portfolio of over 200 products from wide range of therapeutic categories both in active pharmaceutical ingredients and finished dosages.

Hetero’s manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. Majority of them are approved by the various regulatory authorities of USFDA, WHO-Geneva, Australian TGA, Spanish agency of medicines & health care products, ANVISA-Brazil, IDA-Netherlands etc., With full-fledged marketing capabilities, the company has been able to market its products in over 138 countries across the globe.

Hetero Drugs is the parent company in the Hetero group of companies and other companies which are part of the group are Hetero Labs, Hetero Research Foundation, Symed Labs Limited, Cirex Laboratories, Genx Laboratories and also foreign subsidiaries such as Invagen Inc., in USA and Richmond Labs in Argentina, etc., Also now Hetero has its own retail chain of pharmacy outlets in India named as Hetero Pharmacy.

For over 15 years, Dr. Goel has been advancing a new scientific frontier called Nanobiophysics.

Dr. Anita Goel, MD, PhD, founded Nanobiosym® as an R&D innovation engine and hi-tech incubator at the convergence of physics, nanotechnology and biomedicine. Over the past 15 years, her pioneering contributions to this interface have been recognized globally by prestigious honors and awards. Her work at Nanobiosym has received multiple awards from US Governmental agencies such as Defense Advanced Research Projects Agency (DARPA), Department of Defense (DOD), Department of Energy (DOE), Air Force Office of Scientific Research (AFOSR) and US Defense Threat Reduction Agency (DTRA). Under her leadership, the Nanobiosym Team has successfully delivered on multiple contracts on time and within budget. She established Nanobiosym® Diagnostics to commercialize the Gene-RADAR® technology platform to empower people worldwide with rapid, accurate and portable diagnostic devices. She launched the Nanobiosym® Global Initiative to build innovative partnerships with academic, commercial, and global thought leaders, NGO’s, industries, governments and global organizations who can help bring disruptive technologies like Gene-RADAR® to sustainably address some of the greatest unmet needs in both the developing and developed worlds.

A Harvard-MIT trained physicist and physician, Dr. Goel was named as one of the world’s “Top 35 Science and Technology Innovators under the age of 35” by MIT Technology Review. Among other awards and prizes, she received the “Global Indus Technovator Award” from MIT, an honor recognizing the contributions of top leaders working at the forefront of science, technology, and entrepreneurship. She holds a PhD in Physics from Harvard University, an MD from the Harvard-MIT Joint Division of Health Sciences & Technology (HST), and a BS in Physics with Honors and Distinction from Stanford University.

Dr. Goel has a deep passion for fundamental science, especially elucidating the physics of living systems at the nanoscale. Her work in applied science harnesses these fundamental insights to develop next-generation nanotechnology platforms like Gene-RADAR® for portable disease detection and nanosystems for novel energy harvesting and biocomputing applications. Some of her recent publications include “Molecular Evolution: a role for quantum mechanics in the dynamics of molecular machines that read and write DNA,” in the book Quantum Aspects of Life, and “Tuning DNA Strings: Precision Control of Nanomotors” in Scientific American, India edition and “Harnessing Biological Motors to Engineer Systems for Nanoscale Transport and Assembly” in Nature Nanotechnology.

Dr. Goel has been an featured keynote speaker at many major international conferences, symposia, and university colloquia and often gives Guest Faculty Lectures at Harvard and MIT. She was a featured speaker at the 2010 TEDMED Conference, 2010 TedxAmsterdam and 2010 INK Conference in association with TED India. She was invited to chair a Roundtable on “Using Science and Technology as a Tool for International Diplomacy” at the 2009 Science and Technology in Society Forum in Kyoto, Japan.  Last year, Dr. Goel was invited to attend a workshop sponsored by the President's Innovation and Technology Advisory Committee, which aimed to inform implementation of the President's Strategy for American Innovation.  While at Stanford, she envisioned building new hi-tech bridges between developed and developing world economies and founded and chaired an international conference and think tank (SETU – Sanskrit for ‘bridge’), comprised of world leaders from academic, business, socio-political, and humanitarian arenas.

Dr. Goel is a Member of the Board of Overseers of the Boston Museum of Science and a Charter Member of TiE (The Indus Entrepreneurs, a global organization of successful entrepreneurs engaged in the cycle of wealth creation and giving back to society). Dr. Goel is also a Fellow of the World Technology Network, a Fellow-at-Large of the Santa Fe Institute, an Associate of the Harvard Physics Department and an Adjunct Professor of the BEYOND Institute for Fundamental Concepts in Science and Arizona State University. She also serves on the National Board of the Museum of Science and Industry, the International Advisory Board of the Victoria Institute of Science and Technology, and on the Nanotechnology Advisory Board of Lockheed Martin Corporation.